SciBase Receives Additional Order from Castle Biosciences
SciBase Holding AB announced it has received an additional order from Castle Biosciences to accelerate an ongoing clinical study. The collaboration focuses on dermatological applications.
SciBase Holding AB, a company specializing in AI-based devices for dermatology, has received a follow-on order from Castle Biosciences. The order is intended to accelerate an ongoing clinical study.
The collaboration leverages SciBase's technology in the field of dermatoscopy. The specifics of the study and the value of the additional order have not been disclosed.
This order signifies an extension of the existing partnership between SciBase and Castle Biosciences. It is expected to further validate the use of AI in dermatological diagnostics.
SciBase aims to provide AI-driven solutions for the detection and prevention of skin conditions.